Canadian Pharmacy Blog

The FDA has granted marketing clearance for drug oxcarbazepine (Trileptal®, Novartis) tablets and oral suspension for use as monotherapy in children four years of age and older with partial seizures. This is the first antiepileptic drug to be approved as a single-agent therapy in children since 1978. Many children with epilepsy take multiple medications to [...]

The FDA has approved an IV formulation of levetiracetam (Keppra tablet, UCB) solution as an infusion for the adjunctive use in the treatment of partial-onset seizures in adults with epilepsy. The 100-mg/ml injection is intended as an alternative when oral administration of levetiracetam is temporarily not feasible. When patients are switched from the oral to [...]